The forecast for respiratory system medicine sales in Germany from 2024 to 2028 indicates a steady upward trend. The year-on-year growth rates suggest a consistent increase, reflecting a positive outlook for the sector.

Between 2024 and 2028, the compound annual growth rate (CAGR) signals a robust expansion, driven by rising demand and advancements in respiratory treatments. As of 2023, the sales stood at a lower level, which highlights the significant potential for growth projected in these forecasts.

Future trends to watch for include:

Further innovations in therapies and treatments, potentially driving demand.
Healthcare policy changes that could impact accessibility and sales.
Economic factors affecting the disposable income and healthcare spending patterns.
The impact of demographic changes, particularly an aging population, increasing need for respiratory care.